| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.06 |